Patients carrying the *1 allele in addition to another normal function allele may have increased metabolism of warfarin as compared to patients with at least one copy of a decreased or no function allele. Other genetic and clinical factors may also affect warfarin metabolism. This annotation only covers the pharmacokinetic relationship between CYP2C9 and warfarin and does not include evidence about clinical outcomes.